ZURICH, Nov. 6, 2025 /PRNewswire/ -- NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a biotechnology company advancing transformative therapies for…
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont., Nov. 6, 2025 /PRNewswire/ -- Golden Helix, Inc. announced the…
Sustained acoustic medicine from ZetrOZ Systems supports recovery when players face intense physical demands, such as an 18-inning game. TRUMBULL,…
An evidence-based look at a modern therapy advancing wellness and regenerative medicine WEST PALM BEACH, FLORIDA / ACCESS Newswire /…
MESA, ARIZONA / ACCESS Newswire / November 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall…
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an…
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate…
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate…
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of…
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of…